⌘K

Login Start Free

Home/Filings/4/0001144204-16-085397

4//SEC Filing

IMMUNE PHARMACEUTICALS INC 4

Accession 0001144204-16-085397

CIK 0001208261operating

View on SEC.gov Company Profile

Filed

Feb 29, 7:00 PM ET

Accepted

Mar 1, 6:08 PM ET

Size

7.5 KB

Accession

0001144204-16-085397

Insider Transaction Report

Form 4

Period: 2016-02-23

IMMUNE PHARMACEUTICALS INCIMNP

Director

Transactions

Award
Stock Option
2016-02-23+40,000→ 40,000 total
Exercise: $0.43Exp: 2026-02-23→ Common Stock (40,000 underlying)
Award
Stock Option
2016-02-23+50,000→ 50,000 total
Exercise: $0.43From: 2016-02-23Exp: 2026-02-23→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The stock options shall vest in equal quarterly installments over a one-year period.

Documents

1 file

4
v433160_form4.xmlPrimary
FORM 4

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001208261

Filing Metadata

Form type: 4
Filed: Feb 29, 7:00 PM ET
Accepted: Mar 1, 6:08 PM ET
Size: 7.5 KB

View on SEC.gov